(Adnkronos) - In questo numero:
Il dermatologo Paro Vidolìn su vitiligine ed esposizione al sole: “sì ma con crema specifica per patologia”
A Palazzo Lombardia incontro su salute e prevenzione della Trombosi venosa profonda nel mondo dei trasporti
La psicoanalista Adelia Lucattini, nei ragazzi gioco d’azzardo specchio di depressione e disturbo bipolare
E ancora
Presentati i risultati del progetto PMLAb per promuovere la protezione dei pazienti dal Covid19 con profilassi pre-esposizione
“Prevenzione consapevole in età adulta”: i risultati della ricerca di Cittadinanzattiva Lazio
Con terapie antiretrovirali per Hiv soppressa in breve tempo la replicazione del virus
Ail, 55 anni di sostegno alla ricerca per i pazienti con tumori ematologici
Siàarti, al congresso Area culturale dolore di Palermo oltre 500 anestesisti e rianimatori
Il dermatologo Paro Vidolìn su vitiligine ed esposizione al sole: “sì ma con crema specifica per patologia”
A Palazzo Lombardia incontro su salute e prevenzione della Trombosi venosa profonda nel mondo dei trasporti
La psicoanalista Adelia Lucattini, nei ragazzi gioco d’azzardo specchio di depressione e disturbo bipolare
E ancora
Presentati i risultati del progetto PMLAb per promuovere la protezione dei pazienti dal Covid19 con profilassi pre-esposizione
“Prevenzione consapevole in età adulta”: i risultati della ricerca di Cittadinanzattiva Lazio
Con terapie antiretrovirali per Hiv soppressa in breve tempo la replicazione del virus
Ail, 55 anni di sostegno alla ricerca per i pazienti con tumori ematologici
Siàarti, al congresso Area culturale dolore di Palermo oltre 500 anestesisti e rianimatori
Category
🗞
NewsTranscript
00:00In this issue, the dermatologist Paro Vidolin on vitiligin and exposure to the sun,
00:15CIMA with specific cream for pathology, at Palazzo Lombardia meeting on health and prevention
00:21of deep venous thrombosis in the world of transports, the psychoanalyst Adelia Lucattini
00:27presented the results of the PMLAB project to promote the protection of patients from COVID-19 with pre-exposure prophylaxis.
00:41Aware prevention in adulthood, the results of the research of Cittadinanza Attiva Lazio,
00:47with antiretroviral therapies for HIV suppressed in a short time the replication of the virus.
00:53AIL, 55 years of research support for patients with hematological tumors.
00:59SIARTI, at the Palermo Cultural Area and Pain Congress, over 500 anesthetists and reanimators.
01:13People suffering from vitiligin, chronic autoimmune pathology that affects the melanocytes of the skin,
01:17causing the typical depigmentations suffered in Italy by 330,000 people, can expose themselves to the sun,
01:23but following some important precautions.
01:25To begin, as explained by the dermatologist Andrea Paro Vidolin,
01:29responsible for the Center of Photodermatology of the Israeli Hospital of Rome,
01:33from the sunscreen, essential to protect against ultraviolet rays in the right way.
01:37The sun is, let's say, on the one hand an ally, on the other hand a bit of an enemy,
01:43because certainly the increase of the contrast between the normally pigmented part and the vitiligin,
01:49this can be a problem for patients affected by vitiligin.
01:53But today there are strategies, sunscreens dedicated to pathology,
01:57so the possibility of going to use a sunscreen with high protection, 50+, on the normal skin,
02:05and a dedicated sunscreen, therefore a sunscreen that has a slightly higher filtration for UVA,
02:11so maybe a factor of 30, and a factor of 15 for UVB.
02:14UVB is what stimulates melanocytes, so even under the sun we can have a therapeutic opportunity
02:22and therefore continue what we do during the winter period.
02:25With sunscreens you can easily expose yourself, of course always adopting the general rules of sunscreen,
02:33so certainly after 2-3 hours of exposure it is advisable to use a higher factor,
02:37to avoid the most central time of the day, so always safeguarding the skin in general,
02:43even regardless of the pathology.
02:45But not only, and today the first specific drug for vitiligin is available.
02:49Lately, after 35-40 years, the first drug dedicated to this pathology has been released.
02:56It is a topical drug that acts on very particular receptors,
03:02and this is very important both for the therapeutic results of this drug,
03:07but also because it is the first time that we have a drug in which the indication is specific for a pathology,
03:13so today it is a pathology and no longer considered as an aesthetic problem.
03:19Of course there are well-consolidated therapies, which are mainly phototherapy,
03:27so both the Total Body cabins for greater extensions of vitiligin,
03:31and the lasers, so the localized phototherapy, the targeted phototherapy,
03:36so the possibility to selectively irradiate the spots.
03:40Both the two therapies can also be associated,
03:45today there are very interesting works, let's say of the last months,
03:49in which the association between phototherapy and the drug can be even more advantageous.
03:55Thanks to the Winnie Harlow model, which has become known as the modern face of this pathology,
03:59stating that vitiligin is simply another difference, like small ears or lentils,
04:04the disease has also become social.
04:06It can therefore be said with certainty that these last years have been very important,
04:10both for the cure and for the knowledge of this pathology by people.
04:13Still a lot, however, must be done to bring down those taboos linked to the light spots of the skin,
04:17typical of vitiligin, a pathology of which on June 25 the World Day is celebrated.
04:22This is the occasion for a DOC initiative on the Tiber Island of Rome,
04:25in the Antistante Square of the Israeli Hospital, which will take place on Sunday, June 30,
04:29to which everyone is invited to participate.
04:31We must always do more, let's say, for this pathology,
04:34which certainly creates, let's say, great psychological problems for patients,
04:39let's say, affected by vitiligin, especially, let's say, in adolescents.
04:43So we must always do more, make it known more and more,
04:47even in social networks it is certainly important to talk about it
04:51to disseminate, in short, the message of this pathology.
04:54And precisely for this reason, we, on June 30,
04:58as every year at our hospital, at the Israeli Hospital,
05:01we will do an open day dedicated, let's say, to this pathology,
05:05with free visits, in short, for patients,
05:08and also a small mini-conference to illustrate all those
05:12that are new treatments for this pathology.
05:15Because social, yes, it can lead people astray,
05:18but the visit with the specialist is still essential.
05:20Social can be, let's say, a help, but the visit, let's say,
05:24from the specialist is absolutely essential to establish
05:27what are the characteristics, let's say, of vitiligin
05:30and the most suitable treatments for each single patient,
05:33because a patient, in the end, let's say, is not the same as the other.
05:40Despite being the third most common cardiovascular disease,
05:44thrombosis is a silent killer.
05:46There is little talk about it and sometimes it can be lethal for the patient.
05:50However, it can often be prevented,
05:52that's why it is important to be more aware of thrombosis.
05:55To prevent, inform and educate on this particular pathology
05:59were the three cardinals of the meeting
06:01Prevention in Travel, More Movement, Less Thrombosis,
06:04organized by the Lombardy Region in collaboration with the association
06:07Vincere la Thrombosi, near the Marco Piaggi Hall
06:10of the Lombardy Palace in Milan,
06:12where they talked about prevention and health in the world of transport.
06:15It is also an ethical and moral question for the Lombardy Region
06:20and we believe in it, we invest in it,
06:22because we transport a lot of people,
06:25whether they are tourists, commuters and even students,
06:29and it is right to provide them with security,
06:32but to do this we must also preserve the good state of service of the operators,
06:40the tram operators, the drivers and all those who operate in this world
06:45so complex and complicated,
06:47but which serves 10 million Lombard citizens,
06:51as well as a lot of tourists who arrive in our region.
06:55The Lombardy Region has equipped 3 Nord trains,
06:58through North Railways and FNM,
07:00209 trains of the latest generation,
07:03with innovative ergonomics designed to reduce
07:06the psychosocial risks related to the profession of the driver.
07:10This is just one of the aspects put in place by 3 Nord
07:14for the prevention and safety of their employees.
07:17In good substance we have implemented a preventive medicine monitoring system,
07:23which is a fringe benefit that the company gives with corporate welfare,
07:28so that all those who want to voluntarily participate
07:32have the opportunity to do a check-up throughout the year
07:35and then to do a whole series of medical checks.
07:39The second part, which is then linked to the obligation of law,
07:43is that of the application of everything related to health care
07:47provided by the law 81,
07:50and then the other fundamental thing is to try to monitor the lifestyles,
07:55giving advice from our medical service,
07:59which in good substance, with our competent medical coordinator,
08:03gives a series of indications on healthy living.
08:06In good substance, then, the most important thing
08:09is that we have put in place a system
08:11linked to the verification of stress of correlated work.
08:14This is also an obligation of law,
08:16but we have gone a little further,
08:18trying to put in this questionnaire
08:20a whole series of data that can be used by the workers
08:23to have very plausible indicators,
08:25to then make very articulated proposals,
08:28such as the discussion of ergonomics,
08:30such as, for example, the discussion of the assessment
08:33linked to the work activities and the shift.
08:42From sports and VIP betting to online gambling
08:45and even to credits and wins,
08:47more and more often young people rely on luck
08:49with the hope of obtaining extraordinary wins
08:51that allow them not to work, travel and improve their lives,
08:54without realizing, instead,
08:56to become victims of gambling.
08:58Two recent studies conducted,
09:00one by Nomisma, the other by Sapar,
09:02and re-elaborated by the Slots Games editorial,
09:04have in fact highlighted how this practice
09:06has increased a lot in recent years among young people.
09:09In 2023, 37% of teenagers aged 14 and 17
09:12played gambling,
09:14with 9% more than in 2021,
09:16and 14% declared to be a frequent user,
09:19playing at least once a week.
09:21Particularly worrying results
09:23if we consider that we are talking about minors
09:25and that, therefore, they should not have access
09:27to this type of content.
09:28Access is certainly facilitated
09:30and difficult to control by parents
09:32due to the massive use, which for some time now,
09:34has been made of smartphones and the Internet,
09:36which have in practice broken the wall
09:38of prohibition and illicit,
09:40opening a freedom to which many young people,
09:42and not only, are not yet ready.
09:44To demonstrate this, the fact that,
09:46among Generation Z, 64% choose the Internet
09:48to play and bet,
09:50with an increase of 18% compared to 2021,
09:52and that young people's favorite games
09:54are betting,
09:56in particular the sports ones, 31%,
09:58events, 26%,
10:00or hippies, 16%.
10:02The number of boys who go physically
10:04to a point of play is declining,
10:06and if they do, it is to buy Gratte Vinci, 40%,
10:08or to bet, 29%.
10:10And to play more are the young people
10:12of Central Italy, 6%,
10:14compared to those of the North, 1%
10:16and the South, 2%.
10:18To try to curb this worrying phenomenon,
10:20the Ministry of Health,
10:22and the Association of Children and Adolescents
10:24of Italy,
10:26have set up a survey
10:28on the essential levels of assistance.
10:30But how do these young people
10:32deal with this pathology?
10:34We asked Adele Ducattini,
10:36a psychiatrist and psychoanalyst
10:38from Rome,
10:40who respects children and adolescents.
10:42In most cases,
10:44it is a mirror of a underlying disorder,
10:46or a depression,
10:48or a bipolar disorder,
10:50that needs to be cured
10:52so that they can improve.
10:54It is quite natural for children
10:56to have a confusion
10:58between the internal world
11:00and the external world.
11:02If in this phase electronic games
11:04consolidate this confusion
11:06and do not allow development
11:08and maturation with a proper separation
11:10between external reality and desires,
11:12what happens is that in adolescence
11:14they will continue to play,
11:16simply by changing the type of game.
11:18But they will become football, sports,
11:20or their own gambling game.
11:22At first a game,
11:24and then they develop a dependency,
11:26which becomes a need.
11:28What should parents do at this point?
11:30In adolescence,
11:32parents can certainly help
11:34their children, trying to talk to them,
11:36to observe them, to understand
11:38which games they play,
11:40both online and with friends,
11:42and above all, to pay attention
11:44to the money they spend.
11:46Prevention is certainly
11:48the best weapon,
11:50both the prevention of psychological disorders,
11:52depression or bipolar disorders
11:54that occur in childhood,
11:56but also psychological disorders
11:58that occur in adolescence,
12:00because they often associate
12:02with addictions,
12:04and gambling is one of them,
12:06and among other things, one of the most insidious,
12:08because it is not considered toxic
12:10and young people do not manifest
12:12physical disorders, especially at the beginning.
12:14What are the solutions to adopt
12:16to prevent young people from falling into
12:18gambling addiction?
12:20As soon as parents realize
12:22that their children play gambling,
12:24it is important that they turn to professionals,
12:26specialists and psychoanalysts,
12:28so that they can start a specific therapy,
12:30which can be individual or family-based,
12:32in order to solve
12:34both the underlying problem,
12:36if there is one,
12:38depression or bipolar disorder,
12:40or addiction itself,
12:42among others.
12:44What are the solutions to adopt
12:46to prevent young people from falling into
12:48gambling addiction?
12:50Elaborate address lines
12:52that can simplify the management
12:54of the predisposition prophylaxis,
12:56from identification to the appointment
12:58of immunocompromised patients.
13:00This is the intention of the Project
13:02Prevention Management Laboratory,
13:04designed by DEFA Forum
13:06with the support of AstraZeneca Italy,
13:08whose final results were presented
13:10for the management of the COVID-19
13:12prophylaxis as a paradigm of a new
13:14organizational model.
13:16In fact, despite the circulation of the virus
13:18and its endemic phase,
13:20the disease continues to hit.
13:22In 2023, 10,500 deaths were recorded
13:24and in the first half of 2024
13:261,500 are already counted,
13:28as well as many hospitalizations,
13:30even in intensive care.
13:32Therefore, prevention becomes
13:34fundamental, especially for
13:36immunocompromised patients.
13:38These are useful tools
13:40to prevent
13:42infection in these patients
13:44and that, if the infection is acquired,
13:46it can have
13:48a particularly serious outcome.
13:50Obviously, the serious immunodepressed
13:52is the one who responds
13:54even less to vaccination.
13:56This does not mean that they should not be vaccinated,
13:58but that we must think of something more.
14:00We have effective antiviral
14:02drugs against the virus,
14:04but they are only used
14:06once the infection
14:08has occurred.
14:10For prevention, we have
14:12monoclonal antibodies.
14:14We have used them,
14:16we have had an extremely effective one,
14:18which lasts about six months.
14:20With a single supply,
14:22we have kept our patients under control.
14:24This variant virus
14:26has become less sensitive
14:28to this monoclonal antibody,
14:30but we are about to have a new one.
14:32We must take this path again
14:34and make the prophylaxis in these patients.
14:36In this context, the PlanLab project,
14:38in the definition of a new
14:40organizational model to promote
14:42patient protection through
14:44pre-exposure prophylaxis, is essential.
14:46In the field of prevention,
14:48thanks to the use
14:50of this monoclonal antibody
14:52in active prevention
14:54for COVID-19,
14:56the organizational model
14:58defined by all stakeholders,
15:00professionals, other scientific societies,
15:02will be a functional
15:04support for the regions,
15:06ASLs, in support of
15:08better hospital and
15:10territorial assistance
15:12in the field of vaccine prevention.
15:20Information as a method,
15:22accessibility as an organizational challenge,
15:24prevention as a fundamental action of public policy,
15:26with a focus on the vaccine for the Herpes Zoster.
15:28These are the macro areas of work
15:30in which 433 citizens
15:32and 192 health workers
15:34took part in an aware prevention
15:36in the adult age,
15:38presented in Rome by Cittadinanza Attiva Lazio
15:40to investigate the current state of knowledge
15:42on the value of prevention.
15:44The work has shown
15:46very positive signals
15:48regarding the quality of the service
15:50and therefore the point of view
15:52of the citizens towards this aspect
15:54has certainly been very, very satisfactory.
15:56A first big issue, however,
15:58is the lack of information on vaccines,
16:00their safety, quality, effectiveness
16:02and possible side effects.
16:0430.6% of the participating citizens
16:06have in fact declared
16:08that they have not been properly informed
16:10about the available vaccines
16:12and that more than half of the cases
16:14is the staff of the vaccination center
16:16to provide the information,
16:18followed by the general medicine doctor.
16:20The two most highlighted vaccinations
16:22are for COVID-19, 45%
16:24and anti-influenza, 29%.
16:26Lack of information on the availability
16:28of vaccines in the adult age,
16:30when and where to get them,
16:32the effects of the vaccines
16:34and their management.
16:36Moreover, the majority of citizens
16:38believe that among the reasons
16:40that discourage people
16:42from getting vaccinated
16:44are the lack of information,
16:46the fear of possible side effects
16:48and contraindications
16:50and often contradictory information
16:52among the requests
16:54of the vaccination center.
16:56We have a situation
16:58linked to information
17:00that should certainly be improved
17:02and made more and more
17:04widespread and accessible
17:06both for citizens
17:08and health workers.
17:10As far as accessibility is concerned,
17:12there is a very strong preference
17:14by citizens
17:16to be able to carry out
17:18the vaccines
17:20in the right places
17:22to carry out vaccines
17:24in the adult age
17:26in the places closest
17:28to their work and life places
17:30so pharmacies,
17:32general medicine studies,
17:34where to work,
17:36all places of proximity.
17:38While as far as
17:40accessibility to vaccinations
17:42is concerned,
17:44from the point of view of the operators,
17:46the preference goes to the study
17:48of the general medicine doctor.
17:50of the vaccine against herpes zoster, which despite the fact that it is part of the EIA,
17:53the essential levels of assistance, and therefore represents an obligatory objective for institutions
17:58and is offered by the region, it is administered little, therefore evident a need to intervene,
18:03improving the information and increasing its use.
18:05This logically means giving greater vaccine coverage to fragile people who need more
18:13attention and therefore having a response also to an EIA and therefore to criteria of
18:18creativity and effectiveness that the vaccine gives.
18:21In general, however, we must recognize that the survey has certainly given many positive
18:26aspects.
18:27We will have to work, this is the commitment that we have taken, together with the region,
18:31together with the operators of the vaccination centers, to increase the adhesion to vaccination
18:37for herpes zoster and to ensure that the theme of information and accessibility becomes
18:43a common heritage in all places in the region of Lazio.
18:48A quality and expectation of life that up to 30 years ago was unthinkable is the one
18:56that people with HIV can have today, as long as they follow the therapy with constancy
19:01and regularity, avoiding that resistance to drugs develops and that the infection progresses.
19:06Therapeutic adherence and resistance are at the center, in fact, of HIV, we are still talking about it,
19:11the new initiative in the field of HIV, we are talking about it, the awareness campaign
19:16promoted by Gilead Sciences.
19:18With the sponsorship of 16 patient associations, the Italian Society of Infectious Diseases
19:23and Tropical Diseases and the Italian Conference on AIDS and Antiviral Research, launched on
19:28November 23 and precisely on the occasion of the ICAR Congress, which takes place in Rome
19:33from 19 to 21 June, new content and informative materials are presented, designed to improve
19:39the dialogue between doctors and people with HIV.
19:41We have transformed this infection from being a deadly disease, a chronic infection,
19:49thanks to therapies that were in a single small pill, when previously they had to take
19:56at least 30 a day, and this was the biggest initial transformation, let's say.
20:04In the meantime, we have provided therapies that allow the patient to live a life
20:10comparable to that of a healthy person.
20:14New formulations are coming, drugs that are increasingly going towards a reduction
20:21of the assumption, because we are talking about formulations even twice a year, even if
20:27for us the final goal remains and will remain the cure.
20:32Thanks to antiretroviral therapies, the suppression of viral replication is achieved in a short time,
20:38which reduces the risk of transmission.
20:40We have extremely powerful drugs, extremely safe for the patient, which if started in a
20:46very early way and taken in a correct way by the patient, on the one hand, they manage
20:51to prevent the virus from causing damage within our body and, on the other hand, they freeze
20:57the viral replication, so they block the ability of the virus to reproduce within
21:01our body and, as a consequence, they also prevent the virus from being transmitted to other people.
21:08This evidence is known as U equals U, undetectable, untransmittable,
21:13that is, not detectable, not transmissible, therefore zero to the risk of transmission
21:18of the virus to other people.
21:19This is a scientific evidence demonstrated by important studies that must be absolutely
21:24diffused, because it is a very powerful means to reduce stigma and, above all, it is a means
21:31to stop infections, because people who go to get tested and who should discover
21:39that they have HIV can immediately access therapies and, in a short time, in addition to having
21:46a good quality of life, not transmit the virus to other people.
21:51Therefore, the role of associations is very important in disseminating this scientific evidence
21:56that, unfortunately, is not yet known to the most, it is known only to the employees of the laboratories.
22:05For 55 years, he has been supporting scientific research in the hematological field and is
22:09on the side of patients so that they never remain alone.
22:12AIL, the Italian Association Against Leukemia, Lymphoma and Myeloma, turns 55 years old
22:18and, in conjunction with the National Day for the Fight Against Leukemia, Lymphoma and Myeloma,
22:23has given life to the 55th anniversary of AIL and to the support of scientific research
22:28for the fight against blood tumors, biomolecular technologies and innovative hematological therapies.
22:34These are 55 very important years during which AIL, together with Italian hematology,
22:42has achieved absolutely unthinkable results until a few years ago.
22:47More than 70% of hematological pathologies today are solved, are cured,
22:55so our commitment is, for all the rest, on which certainly we will not stop.
23:03The progress of scientific research often requires long times,
23:07but in recent years the steps forward have been rapid and revolutionary.
23:12We must realize that, indeed, from one year to the next, we have steps forward.
23:19What does it mean, steps forward?
23:21It means more precise, more accurate and faster diagnostic pathways that allow us to identify
23:27the subtype of disease, of leukemia or of lymphoma, so as to be able to dedicate,
23:33use the new targeted drug, target, as it is said, for that particular pathology.
23:39This is the great step forward.
23:41A faster and more accurate diagnosis and therefore a more targeted therapy.
23:47With his commitment, AIL has contributed to the advancement of knowledge
23:51and to the transfer of them for an optimal management of patients.
23:55AIL has financed projects that have contributed to the identification
23:59of the most common DNA mutations that occur in these subjects.
24:03It is committed to understanding, in large studies on high numbers of patients
24:08treated in the so-called real life, what is the impact of these new drugs
24:14in patients with chronic myeloproliferative nephrasia.
24:17And then, finally, AIL and Gmema are working together to test and strengthen
24:23a network among the different centers of hematology on the national territory,
24:27not only to optimize the management of patients with these diseases,
24:31but also, above all, to improve molecular diagnosis.
24:35Revolutionary progress has been made in the last four years
24:38in the treatment of non-Hodgkin lymphoma, in particular in relapsed and receding lymphomas.
24:43Where the old chemotherapeutic or trapezoidal treatment gave poor results,
24:47the new therapies offer not only clearly better results,
24:51but also a higher quality of life.
24:54These new drugs are immunotherapies in particular,
24:58which aim to reactivate the lymphocytes of the patient itself,
25:02bringing them to engineering in certain laboratories and then refound it,
25:06or specific antibodies, so-called bi-specific,
25:09which aim to activate the same lymphocytes of the patient itself
25:14with an address on a particular antigen that the tumor cells have.
25:23In the splendid cornice of Palazzo Sant'Elia in Palermo
25:26from 19 to 21 June,
25:28the works of the 23rd National Congress of the Cultural Area of Pain and Palliative Cures
25:33organized by the Italian Society of Anesthesia,
25:36Analgesia, Reanimation and Intensive Therapy, the SIARTI, will take place.
25:40More than 500 specialists will participate,
25:42who are dedicated to the medicine of pain and palliative cures,
25:46and the event is chaired by Professor Antonello Gervatano.
25:50We define ourselves as playmakers,
25:52we work in a team with other professionals
25:55and also with other disciplines
25:58to develop the correct treatment of pain and disease.
26:03How many types of pain exist and how many people suffer from it in Italy?
26:08There are many patients who suffer from chronic pain in Italy.
26:12Until recently we did not have precise epidemiological data.
26:17We referred to European studies,
26:20still dated 2016,
26:23but the data also report, in other cases,
26:27an even greater prevalence,
26:29so we are talking about 12-13 million Italian inhabitants
26:34who suffer from chronic pain.
26:37The University of Palermo has also organized theoretical-practical training moments
26:41in the context of a workshop dedicated to the regional logo approaches
26:46to interventional techniques and apartoneurgesia.
26:49SIARTI has 13,000 registered nurses,
26:52more than 1,500 belong to the boards of the scientific society
26:57and in this triennium we have worked a lot
27:00and today in Palermo we also report the results of this work,
27:03which has seen SIARTI and the area of cultural pain
27:06produce good clinical practices, guidelines,
27:09have institutional relationships.
27:11At the moment, the scientific society has a fundamental role.
27:14What are the most innovative approaches to the treatment of pain?
27:18We currently have innovative therapeutic possibilities,
27:22especially in the field of technological innovations.
27:26If we think of the post-pandemic period,
27:31we have certainly enriched ourselves with methodologies
27:35that until before the pandemic were used very little.
27:40For example, telemedicine and teleconsultation,
27:43which allow us to be close to our patients
27:48even when we have difficulties to reach them from a logistical point of view.
28:00This was our latest news,
28:02to contact us you can write to salute-adnchronos.com
28:06Thank you for following us and see you next time!
28:13www.adnchronos.com